Impact of different levels of weight loss on blood pressure in overweight and obese women [0.03%]
不同级别体重减轻对超重和肥胖女性血压的影响
James D Lecheminant,Erik P Kirk,Matthew A Hall et al.
James D Lecheminant et al.
This study sought to determine the impact of different levels of weight loss on blood pressure in overweight/obese women. One hundred fifty-nine overweight/obese women (age 48.7 +/- 9.7, weight 101.3 +/- 18.7 kg, BMI 37.3 +/- 6.6 kg/m(2)) c...
Current trends in pharmacy benefit designs: a threat to disease management in chronic complex diseases [0.03%]
当前的药房福利设计趋势：对慢性复杂疾病管理的威胁
Gary Owens,Matthew F Emons,Jennifer Christian-Herman et al.
Gary Owens et al.
With a focus on those patients who are candidates for treatment with biologic agents, we review the impact that current pharmacy benefit trends have on patients with chronic complex diseases and how they affect opportunities for disease man...
Tine Hansen-Turton,Sandra Ryan,Ken Miller et al.
Tine Hansen-Turton et al.
The need for accessible, affordable, quality health care in the United States has never been greater. In response to this need, convenient care clinics (CCCs) are being launched across the country to help provide care to meet the basic heal...
The boomers are coming: a total cost of care model of the impact of population aging on the cost of chronic conditions in the United States [0.03%]
千禧年浪潮来袭——美国人口老龄化对慢性病医疗费用影响的完全成本照护模型分析
Nancy Garrett,E Mary Martini
Nancy Garrett
The purpose of this study is to estimate the impact of population aging on medical costs over the next five decades in the United States. Specifically, we focus on the impact of aging on the chronic and/or expensive conditions most often in...
Albert I Wertheimer,James M Wilson
Albert I Wertheimer
The results of clinical trials and approved Food and Drug Administration Drug Applications inform decision makers that a drug was effective in its labeled indications without causing unacceptable side effects. But purchasers for large medic...
The economic impact of epoetin alfa therapy on delaying time to dialysis in elderly patients with chronic kidney disease [0.03%]
促红细胞生成素阿尔法治疗对延迟慢性肾脏病老年人透析时间的经济影响
Patrick Lefebvre,Mei Sheng Duh,Samir H Mody et al.
Patrick Lefebvre et al.
The aim of this study was to evaluate the impact of epoetin alfa (EPO) therapy on delaying progression to renal dialysis and quantify the associated medical cost savings in elderly chronic kidney disease (CKD) patients. Elderly (>/=65 years...
Oncology disease management [0.03%]
肿瘤疾病管理
Donald E Fetterolf,Rachel Terry
Donald E Fetterolf
Oncologic conditions are ubiquitous medical illnesses that present a particular challenge for medical management programs designed to address quality and cost issues in patient populations. Disease management strategies represent a reasonab...
Leveraging the trusted clinician: documenting disease management program enrollment [0.03%]
利用可信的临床医生：记录疾病管理计划登记情况
Sharon Glave Frazee,Patricia Kirkpatrick,Raymond Fabius et al.
Sharon Glave Frazee et al.
The objective of this study was to test the hypothesis that an integrated disease management (IDM) protocol (patent-pending), which combines telephonic-delivered disease management (TDM) with a worksite-based primary care center and pharmac...
A conceptual framework for targeting prediabetes with lifestyle, clinical, and behavioral management interventions [0.03%]
针对糖尿病前期的生活方式、临床和行为管理干预的概念框架
Thomas J Biuso,Susan Butterworth,Ariel Linden
Thomas J Biuso
Prediabetes is a condition that does not fall squarely into the primary or secondary prevention domain, and therefore tends to be inadequately addressed by interventions in either health promotion or disease management. Prediabetes is defin...
An innovative health risk measurement technique for disease management [0.03%]
一种创新的健康风险测量技术在疾病管理中的应用
Chris E Stehno
Chris E Stehno